Clinical Trial Update: A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/ Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial update for CT0991 in relapsed/refractory acute myeloid leukemia shows the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CT0991

Snippet

Sponsor: MEI HENG | Conditions: Relapsed/Refractory Acute Myeloid Leukemia(AML) | Phase 1 | Status: NOT_YET_RECRUITING